{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:25:46Z","timestamp":1788488746124,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003186","name":"National Rosacea Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008890","name":"University of Dundee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ecl.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T15:49:50Z","timestamp":1636559390000},"page":"663-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hereditary Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"50","author":[{"given":"Paul J.","family":"Newey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2021.08.003_bib1","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/jbmr.3296","article-title":"Hypercalcemic Disorders in Children","volume":"32","author":"Stokes","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2021.08.003_bib2","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ecl.2021.08.003_bib3","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jbmr.3650","article-title":"Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective","volume":"34","author":"Marx","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2021.08.003_bib5","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1210\/jc.2018-02789","article-title":"New Concepts About Familial Isolated Hyperparathyroidism","volume":"104","author":"Marx","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000491037","article-title":"Familial and Hereditary Forms of Primary Hyperparathyroidism","volume":"51","author":"Cetani","year":"2019","journal-title":"Front Horm Res"},{"key":"10.1016\/j.ecl.2021.08.003_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/his.13306","article-title":"Heritable forms of primary hyperparathyroidism: a current perspective","volume":"72","author":"DeLellis","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.ecl.2021.08.003_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2021.08.003_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cen.14053","article-title":"Clinical genetic testing in endocrinology: Current concepts and contemporary challenges","volume":"91","author":"Newey","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.08.003_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple Endocrine Neoplasia Type 1: Latest Insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2021.08.003_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib12","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/ERC-17-0325","article-title":"Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors","volume":"25","author":"Wells","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2021.08.003_bib13","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib14","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism","volume":"102","author":"van der Tuin","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"31","author":"Newey","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ecl.2021.08.003_bib16","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ecl.2021.08.003_bib17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib19","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib20","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz233","article-title":"Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene","volume":"105","author":"Marx","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib21","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1530\/EJE-15-1028","article-title":"GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts","volume":"174","author":"Mayr","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases","volume":"15","author":"Hannan","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000381622","article-title":"Aetiology, Diagnosis and Surgical Treatment of Primary Hyperparathyroidism in Children: New Trends","volume":"83","author":"Alagaratnam","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ecl.2021.08.003_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/EJE-20-1119","article-title":"Presenting features and molecular genetics of primary hyperparathyroidism in the paediatric population","volume":"184","author":"El Allali","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jamcollsurg.2018.01.007","article-title":"Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism","volume":"226","author":"El Lakis","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ecl.2021.08.003_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cen.14254","article-title":"Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort","volume":"93","author":"Mariathasan","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.08.003_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/EJE-19-0641","article-title":"Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?","volume":"182","author":"Coppin","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/js.2017-00043","article-title":"Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism","volume":"1","author":"Guan","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ecl.2021.08.003_bib29","doi-asserted-by":"crossref","first-page":"K15","DOI":"10.1530\/EJE-18-0778","article-title":"Germline and somatic mosaicism in a family with multiple endocrine neoplasia type 1 (MEN1) syndrome","volume":"180","author":"Beijers","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib30","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/EJE-18-0852","article-title":"Diagnosis of mosaic mutations in the MEN1 gene by next generation sequencing","volume":"180","author":"Coppin","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 3","key":"10.1016\/j.ecl.2021.08.003_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4158\/EP10379.RA","article-title":"Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice","volume":"17","author":"Newey","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ecl.2021.08.003_bib32","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'etude des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib33","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/s41598-020-67424-5","article-title":"Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism","volume":"10","author":"Choi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ecl.2021.08.003_bib34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1245\/s10434-015-4865-9","article-title":"Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure","volume":"23","author":"Nilubol","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ecl.2021.08.003_bib35","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1007\/s00268-016-3624-9","article-title":"Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1","volume":"40","author":"Kluijfhout","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2021.08.003_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ecl.2021.08.003_bib37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","article-title":"Menin: a scaffold protein that controls gene expression and cell signaling","volume":"38","author":"Matkar","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ecl.2021.08.003_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13023-018-0938-8","article-title":"Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients","volume":"13","author":"Marini","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ecl.2021.08.003_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years","volume":"209","author":"Concolino","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.ecl.2021.08.003_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jbmr.4156","article-title":"Multiple Endocrine Neoplasia Type 1 (MEN1) 5'UTR Deletion, in MEN1 Family, Decreases Menin Expression","volume":"36","author":"Kooblall","year":"2021","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2021.08.003_bib41","doi-asserted-by":"crossref","first-page":"E1995","DOI":"10.1210\/jc.2012-2303","article-title":"Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas","volume":"97","author":"Newey","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib42","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1210\/jc.2015-1689","article-title":"Therapeutic Effectiveness of Screening for Multiple Endocrine Neoplasia Type 2A","volume":"100","author":"Machens","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/SLA.0000000000001464","article-title":"Management of the Parathyroid Glands During Preventive Thyroidectomy in Patients With Multiple Endocrine Neoplasia Type 2","volume":"262","author":"Moley","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ecl.2021.08.003_bib44","doi-asserted-by":"crossref","first-page":"T15","DOI":"10.1530\/ERC-17-0266","article-title":"Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms","volume":"25","author":"Guerin","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2021.08.003_bib45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/cen.12978","article-title":"Variability in penetrance of multiple endocrine neoplasia 2A with amino acid substitutions in RET codon 634","volume":"84","author":"Machens","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.08.003_bib46","doi-asserted-by":"crossref","first-page":"T41","DOI":"10.1530\/ERC-17-0202","article-title":"Advances in risk-oriented surgery for multiple endocrine neoplasia type 2","volume":"25","author":"Machens","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2021.08.003_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-14-0818","article-title":"RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation","volume":"172","author":"Valdes","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib48","doi-asserted-by":"crossref","first-page":"T79","DOI":"10.1530\/ERC-17-0354","article-title":"Structure and function of RET in multiple endocrine neoplasia type 2","volume":"25","author":"Plaza-Menacho","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2021.08.003_bib49","doi-asserted-by":"crossref","first-page":"T189","DOI":"10.1530\/ERC-18-0141","article-title":"65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine","volume":"25","author":"Mulligan","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2021.08.003_bib50","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1210\/js.2017-00330","article-title":"Utility of Population-Level DNA Sequence Data in the Diagnosis of Hereditary Endocrine Disease","volume":"1","author":"Newey","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ecl.2021.08.003_bib51","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2021.08.003_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000491039","article-title":"Parathyroid Carcinoma","volume":"51","author":"Cetani","year":"2019","journal-title":"Front Horm Res"},{"key":"10.1016\/j.ecl.2021.08.003_bib53","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/js.2019-00081","article-title":"Pediatric Parathyroid Carcinoma: A Case Report and Review of the Literature","volume":"3","author":"Dutta","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ecl.2021.08.003_bib54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MPH.0000000000000443","article-title":"Parathyroid Cancer in the Pediatric Patient","volume":"38","author":"Davidson","year":"2016","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.ecl.2021.08.003_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ecl.2021.08.003_bib56","doi-asserted-by":"crossref","first-page":"R441","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors","volume":"26","author":"Cetani","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2021.08.003_bib57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2796.2009.02107.x","article-title":"Parafibromin--functional insights","volume":"266","author":"Newey","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ecl.2021.08.003_bib58","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1038\/ncomms12887","article-title":"Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt\/Hedgehog\/Notch pathways","volume":"7","author":"Kikuchi","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ecl.2021.08.003_bib59","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1038\/ncomms6409","article-title":"Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling","volume":"5","author":"Lamoliatte","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ecl.2021.08.003_bib60","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1038\/ncomms6433","article-title":"Cytoplasmic parafibromin\/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis","volume":"5","author":"Jo","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ecl.2021.08.003_bib61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40618-019-01107-5","article-title":"Whole exome sequencing in familial isolated primary hyperparathyroidism","volume":"43","author":"Cetani","year":"2020","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ecl.2021.08.003_bib62","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1038\/s41598-021-82661-y","article-title":"Five patients with disorders of calcium metabolism presented with GCM2 gene variants","volume":"11","author":"Garcia-Castano","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ecl.2021.08.003_bib63","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1210\/jc.2018-02517","article-title":"Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas","volume":"104","author":"Riccardi","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.surg.2017.04.027","article-title":"Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure","volume":"163","author":"El Lakis","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2021.08.003_bib65","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/hmg\/ddy263","article-title":"Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias","volume":"27","author":"Gorvin","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ecl.2021.08.003_bib66","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","article-title":"Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population","volume":"106","author":"Dershem","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ecl.2021.08.003_bib67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jbmr.3241","article-title":"Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-of-Function Galpha11 Mutation","volume":"33","author":"Gorvin","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2021.08.003_bib68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2265.2011.04059.x","article-title":"Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism","volume":"75","author":"Frank-Raue","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2021.08.003_bib69","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa111","article-title":"Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1)","volume":"105","author":"Dharmaraj","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2021.08.003_bib70","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2021.08.003_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2021.08.003_bib72","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.celrep.2017.12.089","article-title":"AP2sigma Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity","volume":"22","author":"Gorvin","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ecl.2021.08.003_bib73","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-18-0049","article-title":"Insights into calcium-sensing receptor trafficking and biased signalling by studies of calcium homeostasis","volume":"61","author":"Gorvin","year":"2018","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib74","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-19-0104","article-title":"Molecular and clinical insights from studies of calcium-sensing receptor mutations","volume":"63","author":"Gorvin","year":"2019","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib75","doi-asserted-by":"crossref","first-page":"bvaa142","DOI":"10.1210\/jendso\/bvaa142","article-title":"Multiple Endocrine Neoplasia Type 1 (MEN1) Phenocopy Due to a Cell Cycle Division 73 (CDC73) Variant","volume":"4","author":"Lines","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ecl.2021.08.003_bib76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-19-0522","article-title":"Whole genome sequencing of apparently mutation-negative MEN1 patients","volume":"182","author":"Backman","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2021.08.003_bib77","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:45:47Z","timestamp":1760175947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852921000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0889852921000797"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2021.08.003","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}